Sunday, December 1, 2019

Sun Pharma to defend antitrust claims over delayed entry of 3 generic drugs in US

Sun Pharma to defend antitrust claims over delayed entry of 3 generic drugs in US Sun Pharma said the litigation had already been disclosed in the company#39;s FY19 annual report.

from Moneycontrol Business News https://ift.tt/2ODfudW

No comments:

Post a Comment

Will proposed US tariffs trigger further Indian market decline? Experts weigh in

Indian stock markets experienced a significant drop on Thursday, with major indices falling around 1 percent. This decline, the steepest sin...